GB1388054A - Nati-inflammatory agents - Google Patents
Nati-inflammatory agentsInfo
- Publication number
- GB1388054A GB1388054A GB2609972A GB2609972A GB1388054A GB 1388054 A GB1388054 A GB 1388054A GB 2609972 A GB2609972 A GB 2609972A GB 2609972 A GB2609972 A GB 2609972A GB 1388054 A GB1388054 A GB 1388054A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- benzoxazinones
- unsubstituted
- compounds
- benzothiazinones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 4
- HQQTZCPKNZVLFF-UHFFFAOYSA-N 4h-1,2-benzoxazin-3-one Chemical class C1=CC=C2ONC(=O)CC2=C1 HQQTZCPKNZVLFF-UHFFFAOYSA-N 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- -1 wherein X is H Chemical class 0.000 abstract 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- MJNPHLBKHKJDEF-UHFFFAOYSA-N 2h-1$l^{4},2-benzothiazine 1-oxide Chemical class C1=CC=C2S(=O)NC=CC2=C1 MJNPHLBKHKJDEF-UHFFFAOYSA-N 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000004995 haloalkylthio group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical class C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/38—[b, e]-condensed with two six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15767871A | 1971-06-28 | 1971-06-28 | |
| CA143149 | 1972-05-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1388054A true GB1388054A (en) | 1975-03-19 |
Family
ID=25667058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2609972A Expired GB1388054A (en) | 1971-06-28 | 1972-06-05 | Nati-inflammatory agents |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US3767653A (enrdf_load_stackoverflow) |
| CH (1) | CH546788A (enrdf_load_stackoverflow) |
| DE (1) | DE2230592A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2147960B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1388054A (enrdf_load_stackoverflow) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4079135A (en) * | 1973-12-13 | 1978-03-14 | Imperial Chemical Industries Limited | Morpholine derivatives as antidepressants |
| US4033951A (en) * | 1973-12-13 | 1977-07-05 | Imperial Chemical Industries Limited | Morpholine derivative of a 1,4-benzothiazin-3-one |
| US4006161A (en) * | 1973-12-26 | 1977-02-01 | Eli Lilly And Company | Thio-substituted 2-oxo-indolines |
| JPS5121827A (en) * | 1974-08-14 | 1976-02-21 | Fuji Photo Film Co Ltd | Shashinyokapuraa |
| US4268301A (en) * | 1978-04-17 | 1981-05-19 | Sumitomo Chemical Company, Limited | 1,4-Benzothiazines |
| AU566869B2 (en) * | 1982-05-11 | 1987-11-05 | Imperial Chemical Industries Plc | Spiro (imidazolidine-4,3'-indoline) 2,2',5-triones |
| ATE41420T1 (de) * | 1984-02-07 | 1989-04-15 | Pfizer | 1,3-disubstituierte 2-oxindole und deren anwendung als analgetische und antiinflammatorische mittel. |
| IE57741B1 (en) * | 1984-03-19 | 1993-03-24 | Pfizer | Process for making 2-oxindole-1-carboxamides and intermediates therefor |
| US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
| US4690943A (en) * | 1984-09-19 | 1987-09-01 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
| US4808601A (en) * | 1984-09-19 | 1989-02-28 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
| US4752609A (en) * | 1985-06-20 | 1988-06-21 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
| DE3545097A1 (de) * | 1985-12-19 | 1987-07-02 | Bayer Ag | 1-h-pyrido-(3,2-b)(1,4)-thiazine |
| US5036099A (en) * | 1987-02-02 | 1991-07-30 | Pfizer Inc. | Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
| EP2886541A1 (en) * | 2013-12-19 | 2015-06-24 | Sanofi | Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases |
| US10906899B2 (en) | 2016-05-10 | 2021-02-02 | Georgia State University Research Foundation, Inc. | Bicyclic fused pyrazole derivatives for the treatment of RSV |
| CN109641042B (zh) | 2016-05-10 | 2023-06-09 | 乔治亚州立大学研究基金会股份有限公司 | 用于治疗rsv的杂环衍生物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3471481A (en) * | 1966-03-28 | 1969-10-07 | Squibb & Sons Inc | Benzothiazines |
-
1971
- 1971-06-28 US US00157678A patent/US3767653A/en not_active Expired - Lifetime
-
1972
- 1972-06-05 GB GB2609972A patent/GB1388054A/en not_active Expired
- 1972-06-22 DE DE2230592A patent/DE2230592A1/de active Pending
- 1972-06-27 CH CH961272A patent/CH546788A/fr not_active IP Right Cessation
- 1972-06-28 FR FR7223399A patent/FR2147960B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2230592A1 (de) | 1973-01-11 |
| FR2147960B1 (enrdf_load_stackoverflow) | 1976-03-05 |
| CH546788A (fr) | 1974-03-15 |
| FR2147960A1 (enrdf_load_stackoverflow) | 1973-03-11 |
| US3767653A (en) | 1973-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1388054A (en) | Nati-inflammatory agents | |
| GB1457078A (en) | Pyrazolo pyridine derivatives | |
| NO952493L (no) | Pyrrolidin- og tiazolidinderivater, deres fremstilling samt medikamenter inneholdende forbindelsene | |
| ES482282A1 (es) | Un procedimiento para la preparacion de 2,3,4,5-tetrahidro- 1h-3-benzazepinas mercapto-substituidas. | |
| GB1353370A (en) | Imidazolpyridine derivatives | |
| GB1343668A (en) | Process for producing quinazolinone derivatives | |
| GB1384097A (en) | Pyrrole compounds and the manufacture thereof | |
| GB1290818A (enrdf_load_stackoverflow) | ||
| GB1424450A (en) | Isoindoline intermediates | |
| GB1457484A (en) | Acylamidocephalosporins | |
| GB1252847A (enrdf_load_stackoverflow) | ||
| GB1364284A (en) | Acylaminophyrrolidinone derivatives their preparation and pharma ceutical compositions containing them | |
| IE39576L (en) | DERIVATIVES OF 3- (p-CHLOROBENZOYL)-2-METHYL- PHENYLACETIC¹ACID | |
| GB1325770A (en) | Pyrimidopyridazine derivatives | |
| GB1480025A (en) | Derivatives of pyrazolo-(4,3-c)pyridimes | |
| GB1421279A (en) | 3-heterocyclicthiomethylcephalosporins | |
| SE7412147L (enrdf_load_stackoverflow) | ||
| GB1420533A (en) | Pyridine derivatives having juvenile hormone activity | |
| GB1383522A (en) | 2-methyl-6-chloropyridines and salts thereof | |
| GB1389505A (en) | 3,4-dihydropyridones their production and their medicinal use | |
| GB1361368A (en) | Pyrido 4,3-c pyridazine compounds | |
| HU902029D0 (en) | Process for producing thio-formamide derivatives and pharmaceutical preparatives containing these compounds | |
| GB1472325A (en) | Substituted-3,3a,4,5,6,7-hexahydropyrazolo-4,3-c-pyridines | |
| GB1229509A (enrdf_load_stackoverflow) | ||
| GB1366241A (en) | Phenylpyridylallylamines and a process for their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CSNS | Application of which complete specification have been accepted and published, but patent is not sealed |